Search results for biomarkers

“Dr. Patrick also discusses emerging interest in metabolic biomarkers such as ceramides and describes adding urolithin A back to her supplement routine. The human findings are most directly relevant to selected muscle outcomes and mitochondrial biomarkers, with longer-term effects on metabolic health and aging still under investigation.”

“Current Landscape of NRF2 Biomarkers in Clinical Trials. Glucosinolates from the Brassica Vegetables and Their Health Effects. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens.”

“A systematic review of 25 human studies reached a similar practical boundary: early trials span exercise, metabolic, inflammatory, and oxidative outcomes, but larger and more rigorous studies are still needed. Hydrogen water may produce selected biomarker changes, while its dose, target population, and meaningful clinical benefits remain unsettled.”

“One of the primary limitations of epigenetic clocks is that their underlying mechanisms are unknown. Commercial applications of the clocks are emerging; however, the clocks are not validated for use as clinical biomarkers for individual use, but rather to look at trends across larger studies.”

“Biomarkers of blood-brain barrier dysfunction can be measured before other pathological hallmarks of Alzheimer's disease, including amyloid plaques and tau tangles.”

“In this clip, Drs. Levine and Patrick discuss genetic and environmental factors that can accelerate or slow epigenetic aging. Dr. Levine also discusses the aging clock she created and how it can be used, along with other biomarkers, to determine an individual's rate of aging.”

“That biomarker experiment does not show that one drink causes clinical disease, but it illustrates how quickly metabolic markers can move. Regular physical activity provides an additional practical tool; it does not cancel the dietary exposure.”

“In one US analysis, only 10.8% of people met the adequate intake for choline. A young-adult biomarker study found that 87% had serum alpha-tocopherol below a proposed adequacy threshold, but only 1% met its clinical-deficiency definition.”

“And one potential strategy for mitigating our risk for Alzheimer's disease as we age is a "cognoscopy" – a battery of assessments that measures some of the key biomarkers associated with the disease and can inform the trajectory of treatment.”